Elevated effector cell sensitivity to Treg-cell suppression that is not associated with reduced Th17-cell expression distinguishes HIV + asymptomatic subjects from progressors

European Journal of Immunology

Volumn 42, Issue 1, 2012, Pages 138-146

  Thorborn, Georgina S ^a   Pomeroy, Laura ^a   Ishohanni, Heidi ^a   Peters, Barry S ^a   Vyakarnam, Annapurna ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

HIV; IL 17; Treg cells

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 2;

ADULT; AGED; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL COUNT; CELL FUNCTION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EFFECTOR CELL; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH17 CELL;

ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DISEASE PROGRESSION; FEMALE; HIV; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES, REGULATORY;

EID: 84855222627     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201141426     Document Type: Article

References (53)

1. Mills, K. H. G., Regulatory T cells: friend or foe in immunity to infection? Nat. Rev. Immunol. 2004. 4: 841-855.
2. Roncarolo MG, B. M., Regulatory T-cell immunotherapy for tolerance to self and foreign antigens in humans. Nat. Rev. Immunol. 2007. 7: 585-598.
3. Curotto de Lafaille, M. A. and Lafaille, J. J., Natural and adaptive Foxp3+regulatory T cells: More of the same or a division of labor? Immunity 2009. 30: 626-635.
4. Aandahl, E. M., Michaëlsson, J., Moretto, W. J., Hecht, F. M. and Nixon, D. F., Human CD4+CD25+regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J. Virol. 2004. 78: 2454-2459.
5. Montes, M. A., Lewis, D., Sanchez, C., Lopez de Castilla, D., Graviss, E. A., Seas, C. and Gotuzzo, E., Foxp3+regulatory T cells in antiretroviral-naive HIV patients. AIDS 2006. 20: 1669-1671.
6. Estes, J. D., Li, Q., Reynolds, M. R., Wietgrefe, S., Duan, L., Schacker, T., Picker, L. J. et al., Premature induction of an immunosuppressive regulatory T cell response during acute Simian immunodeficiency virus infection. J. Infect. Dis. 2006. 193: 703-712.
7. Pereira, L. E., Villinger, F., Onlamoon, N., Bryan, P., Cardona, A., Pattanapanysat, K., Mori, K. et al., Simian Immunodeficiency Virus (SIV) infection influences the level and function of regulatory T cells in SIV-infected rhesus macaques but not SIV-infected Sooty Mangabeys. J. Virol. 2007. 81: 4445-4456.
8. Kinter, A. L., Hennessey, M., Bell, A., Kern, S., Lin, Y., Daucher, M., Planta, et al., CD25+CD4+regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4+and CD8+HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J. Exp. Med. 2004. 200: 331-343.
9. Weiss, L., Donkova-Petrini, V., Caccavelli, L., Balbo, M., Carbonneil, C. and Levy, Y., Human immunodeficiency virus-driven expansion of CD4+CD25+regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 2004. 104: 3249-3256.
10. Nilsson, J., Boasso, A., Velilla, P. A., Zhang, R., Vaccari, M., Franchini, G., Shearer, G. M. et al., HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood 2006. 108: 3808-3817.
11. Eggena, M. P., Barugahare, B., Jones, N., Okello, M., Mutalya, S., Kityo, C., Mugyenyi, P. et al., Depletion of regulatory T cells in HIV infection is associated with immune activation. J. Immunol. 2005. 174: 4407-4414.
12. Tsunemi, S., Iwasaki, T., Imado, T., Higasa, S., Kakishita, E., Shirasaka, T. and Sano, H., Relationship of CD4+CD25+regulatory T cells to immune status in HIV-infected patients. AIDS 2005. 19: 879-886.
13. Kinter, A., McNally, J., Riggin, L., Jackson, R., Roby, G. and Fauci, A. S., Suppression of HIV-specific T cell activity by lymph node CD25+regulatory T cells from HIV-infected individuals. Proc. Natl. Acad. Sci. USA 2007. 104: 3390-3395.
14. Kinter, A. L., Horak, R., Sion, M., Riggin, L., McNally, J., Lin, Y., Jackson, R. et al., CD25+regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8+T cells in vitro. AIDS Res. Hum. Retroviruses 2007. 23: 438-450.
15. Thorborn, G., Pomeroy, L., Isohanni, H., Perry, M., Peters, B. and Vyakarnam, A., Increased sensitivity of CD4+T-effector cells to CD4+CD25+Treg suppression compensates for reduced Treg number in asymptomatic HIV-1 infection. PLoS ONE 2010. 5: e9254.
16. Kolte, L., Gaardbo, J. C., Skogstrand, K., Ryder, L. P., Ersbøll, A. K. and Nielsen, S. D., Increased levels of regulatory T cells (Treg cells) in human immunodeficiency virus-infected patients after 5 years of highly active anti-retroviral therapy may be due to increased thymic production of naive Treg cells. Clin. Exp. Immunol. 2009. 155: 44-52.
17. Gaardbo, J. C., Nielsen, S. D., Vedel, S. J., Ersbøll, A. K., Harritshøj, L., Ryder, L. P., Nielsen, J. O. et al., Regulatory T cells in human immunodeficiency virus-infected patients are elevated and independent of immunological and virological status, as well as initiation of highly active anti-retroviral therapy. Clin. Exp. Immunol. 2008. 154: 80-86.
18. Favre, D., Lederer, S., Kanwar, B., Ma, Z. M., Proll, S., Kasakow, Z., Mold, J. et al., Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog. 2009. 5: e1000295.
19. Favre, D., Mold, J., Hunt, P. W., Kanwar, B., Loke, P., Seu, L., Barbour, J. D. et al., Tryptophan catabolism by indoleamine 2, 3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci. Transl. Med. 2010. 2: 32ra36.
20. Brenchley, J. M., Paiardini, M., Knox, K. S., Asher, A. I., Cervasi, B., Asher, T. E., Scheinberg, P. et al., Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 2008. 112: 2826-2835.
21. Cecchinato, V., Trindade, C. J., Laurence, A., Heraud, J. M., Brenchley, J. M., Ferrari, M. G., Zaffiri, L. et al., Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques. Mucosal Immunol. 2008. 1: 279-288.
22. El Hed, A., Khaitan, A., Kozhaya, L., Manel, N., Daskalakis, D., Borkowsky, W., Valentine, F. et al., Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection. J. Infect. Dis. 2010. 201: 843-854.
23. Prendergast, A., Prado, J. G., Kang, Y., Chen, F., Riddell, L., Luzzi, G., Goulder, P., and Klenerman, P., HIV-1 infection is characterized by profound depletion of CD161+Th17 cells and gradual decline in regulatory T cells. AIDS 2010. 24: 491-502.
24. Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S. and Kazzaz, Z., Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 2006. 12: 1365-1371.
25. Estes, J. D., Harris, L. D., Klatt, N. R., Tabb, B., Pittaluga, S., Paiardini, M., Barclay, G. R. et al., Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic Simian immunodeficiency virus infections. PLoS Pathog. 2010. 6: e1001052.
26. Younes, S.-A., Yassine-Diab, B., Dumont, A. R., Boulassel, M. R., Grossman, Z., Routy, J. P. and Sekaly, R. P., HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+T cells endowed with proliferative capacity. J. Exp. Med. 2003. 198: 1909-1922.
27. Boaz, M. J., Waters, A., Murad, S., Easterbrook, P. J. and Vyakarnam, A., Presence of HIV-1 gag-specific IFN-gamma+IL-2+and CD28+IL-2+CD4 T cell responses is associated with nonprogression in HIV-1 infection. J. Immunol. 2002. 169: 6376-6385.
28. Lawson, J. M., Tremble, J., Dayan, C., Beyan, H., Leslie, R. D. G., Peakman, M. and Tree, T., Increased resistance to CD4+CD25hi regulatory T cell-mediated suppression in patients with type 1 diabetes. Clin. Exp. Immunol. 2008. 154: 353-359.
29. Yates, J., Whittington, A., Mitchell, P., Lechler, R. I., Lightstone, L and Lombardi, G., Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis. Clin. Exp. Immunol. 2008. 135: 44-55.
30. Harari, A., Dutoit, V., Cellerai, C., Bart, P. A., Du Pasquier, R. A. and Pantaleo, G., Functional signatures of protective antiviral T-cell immunity in human virus infections. Immunol. Rev. 2006. 211: 236-254.
31. Ziegler, S. F. and Buckner, J. H., FOXP3 and the regulation of Treg/Th17 differentiation. Microbes Infect., 2009. 11: 594-598.
32. Frebel, H., K. Richter, K. and Oxenius, A., How chronic viral infections impact on antigen-specific T-cell responses. Eur. J. Immunol. 2010. 40: 654-663.
33. Che, K. F., Sabado, R. L., Shankar, E. M., Tjomsland, V., Messmer, D., Bhardwaj, N., Lifson, J. D. et al., HIV-1 impairs in vitro priming of naïve T cells and gives rise to contact-dependent suppressor T cells. Eur. J. Immunol. 2010. 40: 2248-2258.
34. de St Groth, B. F. and Landay, A. L., Regulatory T cells in HIV infection: pathogenic or protective participants in the immune response? AIDS 2008. 22: 671-683.
35. Sousa, A. E., Carneiro, J., Meier-Schellersheim, M., Grossman, Z. and Victorino, R. M., CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J. Immunol. 2002. 169: 3400-3406.
36. Antons, A. K., Wang, R., Kalams, S. A. and Unutmaz, D., Suppression of HIV-specific and allogeneic T cell activation by human regulatory T cells is dependent on the strength of signals. PLoS ONE 2008. 3: e2952.
37. Viglietta, V., Baecher-Allan, C., Weiner, H. L. and Hafler, D. A., Loss of functional suppression by CD4+CD25+regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 2004. 199: 971-979.
38. Clerici, M., Stocks, N. I., Zajac, R. A., Boswell, R. N., Lucey, D. R., Via, C. S. and Shearer, G. M., Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+cell numbers and clinical staging. J. Clin. Invest. 1989. 84: 1892-1899.
39. Miedema, F., Petit, A. J., Terpstra, F. G., Schattenkerk, J. K., de Wolf, F., Al, B. J., Roos, M. et al., Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+T helper cell depletion occurs. J. Clin. Invest. 1988. 82: 1908-1914.
40. Musey, Luwy K., Krieger, J. N., Hughes, J. P., Schacker, T. W., Corey, L. and McElrath, M. J., Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection. J. Infect. Dis. 1999. 180: 278-284.
41. Gurley, R. J., Ikeuchi, K., Byrn, R. A., Anderson, K. and Groopman, J. E., CD4+lymphocyte function with early human immunodeficiency virus infection. Proc. Natl. Acad. Sci. USA 1989. 86: 1993-1997.
42. Moreno-Fernandez, M. E., Zapata, W., Blackard, J. T., Franchini, G. and Chougnet, C. A., Human regulatory T cells are targets for human immunodeficiency virus (HIV) infection, and their susceptibility differs depending on the HIV type 1 strain. J. Virol. 2009. 83: 12925-12933.
43. Oswald-Richter, K., Grill, S. M., Shariat, N., Leelawong, M., Sundrud, M. S., Haas, D. W. and Unutmaz, D., HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol. 2004. 2: e198.
44. Knoechel, B., Lohr, J., Kahn, E., Bluestone, J. A. and Abbas, A. K., Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen. J. Exp. Med. 2005. 202: 1375-1386.
45. Pandiyan, P. and Lenardo, M., The control of CD4+CD25+Foxp3+regulatory T cell survival. Biol. Direct 2008. 3: 6.
46. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L. et al., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006. 441: 235-238.
47. Mills, K. H. G., Induction, function and regulation of IL-17-producing T cells. Eur. J. Immunol. 2008. 38: 2636-2649.
48. Yun Yue, F., Merchant, A., Kovacs, C. M., Loutfy, M., Persad, D., and Ostrowski, M. A., Virus-specific interleukin-17-producing CD4+T cells are detectable in early human immunodeficiency virus type 1 infection. J. Virol. 2008. 82: 6767-6771.
49. Gosselin, A., Monteiro, P., Chomont, N., Diaz-Griffero, F., Said, E. A., Fonseca, S., Wacleche, V. et al., Peripheral blood CCR4+CCR6+and CXCR3+CCR6+CD4+T cells are highly permissive to HIV-1 infection. J. Immunol. 2010. 184: 1604-1616.
50. Kaufmann, G. R., Zaunders, J. J., Cunningham, P., Kelleher, A. D., Grey, P., Smith, D., Carr, A. et al., Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection. AIDS 2000. 14: 2643-2651.
51. Anthony, K. B., Yoder, C., Metcalf, J. A., DerSimonian, R., Orenstein, J. M., Stevens, R. A., Falloon, J. et al., Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover. J. Acquir. Immune Defic. Syndr. 2003. 33: 125-133.
52. Harari, A., Petitpierre, S., Vallelian, F. and Pantaleo, G., Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood 2004. 103: 966-972.
53. Hazenberg, M. D., Otto, S. A., van Benthem, B. H., Roos, M. T., Coutinho, R. A., Lange, J. M., Hamann, D. et al., Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 2003. 17: 1881-1888.